A cure for all ills? The effectiveness of therapeutic and biosimilar pharmaceutical competition in the Netherlands

Research output: Contribution to Journal › Article › Academic › peer-review

98 Downloads (Pure)

Original language	English
Pages (from-to)	57-66
Number of pages	10
Journal	European Pharmaceutical Law Review
Volume	4
Issue number	1
Early online date	26 Mar 2020
DOIs	https://doi.org/10.21552/eplr/2020/1/8
Publication status	Published - 2020

Access to Document

@article{b98e104c36db4075a684ca9fd58f4681,

title = "A cure for all ills? The effectiveness of therapeutic and biosimilar pharmaceutical competition in the Netherlands",

author = "Wolf Sauter and Ilan Akker",

year = "2020",

doi = "10.21552/eplr/2020/1/8",

language = "English",

volume = "4",

pages = "57--66",

journal = "European Pharmaceutical Law Review",

issn = "2511-7157",

publisher = "Lexxion Verlagsgesellschaft mbH",

number = "1",

}

TY - JOUR

T1 - A cure for all ills? The effectiveness of therapeutic and biosimilar pharmaceutical competition in the Netherlands

AU - Sauter, Wolf

AU - Akker, Ilan

PY - 2020

Y1 - 2020

UR - https://www.scopus.com/pages/publications/85107498557

UR - https://www.scopus.com/inward/citedby.url?scp=85107498557&partnerID=8YFLogxK

U2 - 10.21552/eplr/2020/1/8

DO - 10.21552/eplr/2020/1/8

M3 - Article

SN - 2511-7157

VL - 4

SP - 57

EP - 66

JO - European Pharmaceutical Law Review

JF - European Pharmaceutical Law Review

IS - 1

ER -